|
Market Closed -
NYSE
16:00:02 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 151.12 USD | -3.30% |
|
+0.33% | +9.61% |
| 03:20am | Novartis Reports Positive Results from Late-stage Studies for Remibrutinib | MT |
| 10-23 | Novartis AG - Special Call |
| Market Cap | 295B 263B 243B 220B 412B 27,996B 419B 2,928B 1,159B 14,668B 1,107B 1,083B 46,244B | P/E 2026 * |
21.8x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 327B 292B 269B 244B 457B 31,000B 464B 3,242B 1,283B 16,242B 1,226B 1,199B 51,206B | EV / Sales 2026 * |
5.68x | EV / Sales 2027 * | 5.27x |
| Free-Float |
91.66% | Yield 2026 * |
2.81% | Yield 2027 * | 2.94% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| NVS | Delayed | |
CBOE
| NVS | Real-time | |
|
Boerse Muenchen
| NOTA | Real-time | |
|
London S.E.
| 0K9E | Delayed | |
|
Mexican S.E.
| NVS N | End-of-day quote | |
|
Tradegate
| NOTA | Real-time | |
|
Deutsche Boerse AG
| NOTA | Delayed | |
|
Börse Stuttgart
| NOTA | Delayed |
Last Transcript: Novartis AG
| 1 day | -3.30% | ||
| 1 week | +0.33% | ||
| Current month | +6.00% | ||
| 1 month | +5.26% | ||
| 3 months | -2.51% | ||
| 6 months | +3.88% | ||
| Current year | +9.61% |
| 1 week | 149.17 |  | 157.1 |
| 1 month | 139.31 | | 157.1 |
| Current year | 135.55 | | 170.46 |
| 1 year | 121.57 | | 170.46 |
| 3 years | 92.19 | | 170.46 |
| 5 years | 74.09 | | 170.46 |
| 10 years | 66.93 | | 170.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Karen Hale
CMP | Compliance Officer | 58 | 2025-04-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.30% | +0.33% | - | - | 295B | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -1.32% | +2.17% | +37.02% | +69.16% | 444.85B | |
| Weighted average by Cap. | -1.48% | +2.66% | +41.02% | +79.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.49B 51.34B 47.43B 42.98B 80.41B 5,458B 81.74B 571B 226B 2,860B 216B 211B 9,015B | 61.39B 54.82B 50.64B 45.89B 85.86B 5,828B 87.28B 609B 241B 3,053B 230B 225B 9,626B |
| Net income | 14.3B 12.77B 11.8B 10.69B 20.01B 1,358B 20.34B 142B 56.22B 711B 53.68B 52.54B 2,243B | 15.94B 14.24B 13.15B 11.92B 22.3B 1,514B 22.67B 158B 62.67B 793B 59.84B 58.57B 2,500B |
| Net Debt | 31.64B 28.26B 26.1B 23.66B 44.26B 3,004B 44.99B 314B 124B 1,574B 119B 116B 4,962B | 28.7B 25.63B 23.68B 21.46B 40.14B 2,724B 40.8B 285B 113B 1,427B 108B 105B 4,500B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | US$151.12 | -3.30% | 4,358,805 |
| 26-10-22 | US$156.27 | +1.52% | 2,081,375 |
| 26-10-21 | US$153.93 | +0.19% | 1,019,112 |
| 26-10-20 | US$153.64 | +2.29% | 1,356,945 |
| 26-10-19 | US$150.20 | -0.28% | 1,866,732 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
- NVS Stock
Select your edition
All financial news and data tailored to specific country editions
